Literature DB >> 9769231

Abnormal mitochondrial function in myocardium of dogs with chronic heart failure.

V G Sharov1, A Goussev, M Lesch, S Goldstein, H N Sabbah.   

Abstract

Chronic heart failure (HF) is associated with morphologic abnormalities of cardiac mitochondria that include hyperplasia, reduced organelle size and compromised structural integrity. In the present study, we examined mitochondrial respiration in myocardium of 10 normal dogs and 10 dogs with chronic HF (LV ejection fraction 24+/-2%) produced by intracoronary micro-embolizations. Mitochondrial respiratory rates were determined using a Clark electrode in an oxygraph cell containing saponin-skinned muscle bundles. Basal respiratory rate (VO), respiratory rate after addition of substrates, glutamate and malate (VSUB) and state 3 respiratory rate (VADP, after addition of ADP), were measured in tissue samples from the subendocardial and subepicardial LV free wall, interventricular septum and right-ventricular free wall. No differences were observed in basal respiratory rates between normal and HF tissue, while VSUB was significantly lower in HF compared to normal. VADP was 50-60% lower in HF compared to normal tissue (P<0.001). The results indicate abnormal mitochondrial respiratory activity in myocardium of dogs with chronic HF. These findings support the concept of low myocardial energy production in HF that can contribute to the global cardiac dysfunction. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9769231     DOI: 10.1006/jmcc.1998.0739

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  48 in total

1.  Copper sulfate affects Nile tilapia (Oreochromis niloticus) cardiomyocytes structure and contractile function.

Authors:  Kátia Cristina de Andrade Waldemarin; Rosiane Nascimento Alves; Marcelo Emílio Beletti; Francisco Tadeu Rantin; Ana Lúcia Kalinin
Journal:  Ecotoxicology       Date:  2011-12-10       Impact factor: 2.823

2.  Pathophysiology of coronary microembolisation.

Authors:  G Heusch; R Schulz
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 3.  Mitochondria in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  Cardiovasc Res       Date:  2010-07-28       Impact factor: 10.787

Review 4.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

Review 5.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

Review 6.  Metabolic therapy for heart disease: impact of trimetazidine.

Authors:  Hani N Sabbah; William C Stanley
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

7.  Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.

Authors:  Victor G Sharov; Anastassia V Todor; Makoto Imai; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

Review 8.  New aspects of impaired mitochondrial function in heart failure.

Authors:  Mariana G Rosca; Charles L Hoppel
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

9.  Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.

Authors:  Victor G Sharov; Anastassia Todor; Sanjaya Khanal; Makoto Imai; Hani N Sabbah
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

Review 10.  Dynamic organization of mitochondria in human heart and in myocardial disease.

Authors:  Charles L Hoppel; Bernard Tandler; Hisashi Fujioka; Alessandro Riva
Journal:  Int J Biochem Cell Biol       Date:  2009-05-14       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.